Rescue of F508del-CFTR by RXR motif inactivation triggers proteome modulation associated with the unfolded protein response
- PMID: 20044041
- DOI: 10.1016/j.bbapap.2009.12.013
Rescue of F508del-CFTR by RXR motif inactivation triggers proteome modulation associated with the unfolded protein response
Abstract
F508del-CFTR, the most common mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, disrupts intracellular trafficking leading to cystic fibrosis (CF). The trafficking defect of F508del-CFTR can be rescued by simultaneous inactivation of its four RXR motifs (4RK). Proteins involved in the F508del-CFTR trafficking defect and/or rescue are therefore potential CF therapeutic targets. We sought to identify these proteins by investigating differential proteome modulation in BHK cells over-expressing wt-CFTR, F508del-CFTR or the revertant F508del/4RK-CFTR. By 2-dimensional electrophoresis-based proteomics and western blot approaches we demonstrated that over-expression of F508del/4RK-CFTR modulates the expression of a large number of proteins, many of which are reported interactors of CFTR and/or 14-3-3 with potential roles in CFTR trafficking. GRP78/BiP, a marker of ER stress and unfolded protein response (UPR), is up-regulated in cells over-expressing either F508del-CFTR or F598del/4RK-CFTR. However, over-expression of F508del/4RK-CFTR induces the up-regulation of many other UPR-associated proteins (e.g. GRP94, PDI, GRP75/mortalin) and, interestingly, the down-regulation of proteasome components associated with CFTR degradation, such as the proteasome activator PA28 (PSME2) and COP9 signalosome (COPS5/CSN5). Moreover, the F508del-CFTR-induced proteostasis imbalance, which involves some heat shock chaperones (e.g. HSP72/Hpa2), ER-EF-hand Ca(2+)-binding proteins (calumenin) and the proteasome activator PA28 (PSME2), tends to be 'restored', i.e., in BHK cells over-expressing F508del/4RK-CFTR those proteins tend to have expression levels similar to the wild-type ones. These findings indicate that a particular cellular environment orchestrated by the UPR contributes to and/or is compatible with F508del/4RK-CFTR rescue.
Copyright 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17891-6. doi: 10.1073/pnas.0608312103. Epub 2006 Nov 10. Proc Natl Acad Sci U S A. 2006. PMID: 17098864 Free PMC article.
-
Low temperature restoring effect on F508del-CFTR misprocessing: A proteomic approach.J Proteomics. 2009 Dec 1;73(2):218-30. doi: 10.1016/j.jprot.2009.09.001. Epub 2009 Sep 21. J Proteomics. 2009. PMID: 19775599
-
Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR.J Physiol. 2014 May 1;592(9):1931-47. doi: 10.1113/jphysiol.2014.271817. Epub 2014 Mar 3. J Physiol. 2014. PMID: 24591578 Free PMC article.
-
Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the Golgi.FEBS J. 2013 Sep;280(18):4396-406. doi: 10.1111/febs.12392. Epub 2013 Jul 5. FEBS J. 2013. PMID: 23773658 Review.
-
F508del-CFTR rescue: a matter of cell stress response.Curr Pharm Des. 2013;19(19):3476-96. doi: 10.2174/13816128113199990317. Curr Pharm Des. 2013. PMID: 23331026 Review.
Cited by
-
Quantitative proteomic profiling reveals differentially regulated proteins in cystic fibrosis cells.J Proteome Res. 2014 Nov 7;13(11):4668-75. doi: 10.1021/pr500370g. Epub 2014 May 21. J Proteome Res. 2014. PMID: 24818864 Free PMC article.
-
Proteomic identification of calumenin as a G551D-CFTR associated protein.PLoS One. 2012;7(6):e40173. doi: 10.1371/journal.pone.0040173. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768251 Free PMC article.
-
CFTR Deletion in Mouse Testis Induces VDAC1 Mediated Inflammatory Pathway Critical for Spermatogenesis.PLoS One. 2016 Aug 2;11(8):e0158994. doi: 10.1371/journal.pone.0158994. eCollection 2016. PLoS One. 2016. PMID: 27483469 Free PMC article.
-
Recent developments in cystic fibrosis drug discovery: where are we today?Expert Opin Drug Discov. 2025 May;20(5):659-682. doi: 10.1080/17460441.2025.2490250. Epub 2025 Apr 13. Expert Opin Drug Discov. 2025. PMID: 40202089 Review.
-
Targets for cystic fibrosis therapy: proteomic analysis and correction of mutant cystic fibrosis transmembrane conductance regulator.Expert Rev Proteomics. 2010 Aug;7(4):495-506. doi: 10.1586/epr.10.45. Expert Rev Proteomics. 2010. PMID: 20653506 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous